Centella Asiatica Extract Madecassoside 90% Powder HPLC

What is Centella Asiatica Extract Madecassoside 90% 粉 HPLC?

Centella Asiatica Extract Madecassoside 90% Powder HPLC is a highly purified, crystalline pentacyclic triterpene monomer isolated from the aerial parts of ツボクサはasiatica (l)都市 (CAS 34540-22-2)。 Unlike multi-component crude mixtures, this active pharmaceutical-grade phytochemcial is standardized to contain a minimum of 90.0% pure Madecassoside as evaluated via quantitative HPLC-PDA chromatography.

The advanced manufacturing protocol utilizes multi-stage solvent fractioning, macro-porous resin purification, and low-temperature recrystallization to yield a white to off-white fine crystalline powder. The precise particle distribution is milled to ensure 100% passing through a 100-mesh screen (≤ 150 μm), optimizing its chemical dissolution dynamics across continuous cosmetic and dermatological batch processing.

Distributed globally by グリーン・春技術, this active isolate features a controlled bulk density profile of 0.30 – 0.50 g/mL. This fine granularity is engineered to prevent phase separation and pipeline sedimentation, providing raw material compatibility for advanced dermal barrier repair, anti-inflammatory cosmeceuticals, and clean-label topical formulations.

仕様

Quality & Compliance

Compendial Alignment & Regulatory Market Entry: The monomer is standardized to ≥ 90.0% pure trans-isomer via HPLC-PDA validation to prevent UV-Vis estimation errors. It is registered in CosIng for immediate compliance with EU Regulation (EC) No 1223/2009 and fully supports US MoCRA auditing standards.

Toxicological Impurity Control & Heavy Metal Thresholds: Processed via multi-stage filtration to eliminate plant-soil bioaccumulation risks, limits are set at Pb ≤ 2.0 ppm, As ≤ 1.0 ppm, Cd ≤ 1.0 ppm, and Hg ≤ 0.1 ppm. Testing follows USP <233> via ICP-MS to ensure safety in premium periocular applications.

Solvent & Process Residual Monitoring: Vacuum thermal stripping maintains volatile residuals within USP <467> boundaries, capping residual ethanol at ≤ 5,000 ppm via HS-GC-FID. The material is certified 100% ETO-Free and 100% Nanomaterial-Free due to clean thermodynamic crystallization.

Microbiological Release Specification Matrix: Evaluated under USP <61>/<62> to protect cold-process emulsion stability, limits are capped at TAMC ≤ 100 CFU/g and TYMC ≤ 10 CFU/g. Pathogens including E. coli, Salmonella, Pseudomonas aeruginosa, and Staphylococcus aureus are verified as Absent.

Allergen, Cruelty, and Preservation Status: A dedicated botanical processing lineage ensures compliance with Soy-Free, Gluten-Free, and Nut-Free standards. The crystalline matrix is verified Cruelty-Free (no animal testing), un-irradiated, and unpreserved to support a clean-label chemical profile.

Key Advantages

• Optimized Rheology for High-Speed Automated Processing: Maintaining a controlled Bulk Density of 0.30–0.50 g/mL matches the precise volumetric boundaries of automated dosing systems. This engineered particle distribution eliminates mechanical bridging inside hopper feeds, ensuring absolute weight uniformity across manufacturing runs. The non-cohesive crystal structure completely prevents die-sticking on high-throughput rotary tooling machinery operating at high speeds.

• Rapid Cold-Water Dispersion without Formulation Stratification: The fine particle size, locked at 100% through 100 mesh (≤ 150 μm), dramatically accelerates dissolution kinetics in cold-process systems. The powder achieves uniform incorporation into aqueous phases without intensive shear mixing, preventing micro-clumping. This clean wetting dynamic eliminates the risk of pipeline sedimentation during continuous inline liquid operations.

• Compendial Compatibility in Clean-Label Matrices: The hyper-purified monomer isolates pure trans-isomer activity to ≥ 90.0%, ensuring exact active dosing at low incorporation rates. Free from synthetic carriers, fillers, or flow-agents, the crystalline matrix avoids unwanted chemical cross-reactions. This precise purity profile prevents unexpected discoloration or localized matrix thinning common with crude botanical fractions.

• High Thermal Stability under Industrial Stress: The molecular core maintains complete chemical integrity under thermal stress, with a stable melting threshold far above typical manufacturing temperatures. The compound withstands short-duration pasteurization, UHT processing, or vacuum concentration loops without structural degradation or isomerization. This thermal endurance guarantees that the ≥ 90.0% assay limit remains uncompromised post-processing.

Applications

• Advanced Topical Barrier Emulsions: Engineered for high-performance dermo-cosmetic creams and periocular gels, the ≥ 90.0% pure monomer ensures precise active dosing for skin barrier repair. The zero-carrier crystalline profile prevents unexpected color shifts, remaining fully compatible with premium, clean-label white skincare bases.

• High-Throughput Solid Dose Encapsulation: Designed for automated supplement manufacturing, the powder functions seamlessly on rotary capsule filling lines. Locking parameters at 100% through 100 mesh (≤ 150 μm) and a Bulk Density of 0.30–0.50 g/mL optimizes hopper rheology, completely eliminating processing challenges like die-sticking.

• Continuous Liquid Blending Systems: Providing exceptional hydration kinetics for nutricosmetic beverage and liquid filling lines, the fine powder facilitates rapid room-temperature dispersion. This clean dissolving dynamic ensures stable phase homogeneity without continuous high-shear mixing, preventing inline pipeline sedimentation during storage.

• Thermal-Processed Functional Matrices: The core molecule exhibits high thermal stability, making it compatible with manufacturing lines utilizing short-duration pasteurization or UHT processing loops. The pure trans-isomer matrix resists structural degradation, ensuring the ≥ 90.0% assay target remains uncompromised post-processing.

Technical FAQ

Q1: What protocols prevent crystallization and precipitation of Centella Asiatica Extract Madecassoside 90% Powder HPLC in continuous aqueous lotion lines?
A1: The high purity of this isolated pentacyclic triterpene monomer increases crystallization risks under sudden thermal drops. Formulators must maintain an inline solution equilibrium between a pH of 5.5 and 7.5 and incorporate non-ionic solubilizers at a 1:3 ratio relative to the 90.0% pure trans-isomer. Keeping process temperatures at 25°C to 40°C before introducing the oil phase entirely eliminates micellar micro-clumping and inline pipeline sedimentation.

Q2: How does the light density of High-Purity Madecassoside 90% Crystalline Powder impact mechanical weight uniformity during high-speed capsule filling?
A2: Automated manufacturing lines operating above 80,000 units per hour require strict powder rheology control to prevent hopper bridging. Because this standardized Centella asiatica (L.) Urban aerial part extract maintains a lightweight Bulk Density of 0.30–0.50 g/mL, it can generate electrostatic friction. Blending the 100-mesh fine powder with free-flowing silicified microcrystalline cellulose lowers the Hausner Ratio to secure uniform volumetric flow and prevent die-sticking.

Q3: Does short-duration UHT thermal processing cause chemical degradation or Maillard browning in Madecassoside 90% Phytochemical Isolate beverage formulations?
A3: No. The molecular core of this premium standardized Gotu Kola extract isolate is highly stable, with a crystalline melting point threshold spanning 201°C to 205°C. During UHT processing at 135°C to 140°C for 4 seconds, the molecule remains chemically intact without structural isomerization. Maintaining the liquid carrier matrix within a neutral pH range completely blocks acid-catalyzed degradation and secondary Maillard browning.

B2B Sourcing & Global Supply Capabilities

• Scalable Output & Production Capacity: The infrastructure secures a verified annual manufacturing capacity of 180 metric tons for Centella Asiatica Extract Madecassoside 90% Powder HPLC. Continuous raw material sourcing channels and automated crystallization lines maintain an uninterrupted bulk ingredient pipeline, mitigating supply chain disruptions for commercial scale-ups.

• Standardized Bulk Packaging Specifications: Consignments are dispatched in heavy-duty 25 kg cardboard drums lined with double-layer, food-grade polyethylene anti-static barrier bags. This regulatory-compliant configuration maximizes material stability during long-haul transit and prevents moisture migration into the low-hygroscopicity crystal matrix.

• Decentralized European Warehousing & Transit: Immediate regional supply lines are secured through a centralized distribution hub in Paris, France. This strategic European inventory depot cuts logistics lead times, guaranteeing customs-cleared overland delivery within 2 to 5 business days across the EU single market.

• Flexible Low-Volume Factory MOQ: To assist formulation feasibility trials and pilot-scale batch validation, procurement boundaries are lowered to a direct factory minimum order quantity of 1 kg (MOQ 1 kg). This flexible policy eliminates financial overhead for innovative dermo-cosmetic startups and contract manufacturers.

• Customs Clearance Support & Risk Mitigation: The regulatory division provides complete technical document packs—including SDS, Allergen Statements, and non-irradiation clearances—to guarantee seamless transatlantic customs clearance. Active compliance management frameworks isolate downstream brands from cross-border clearance blockages.

• Complimentary R&D Evaluation Lots: Dedicated evaluation quotas provide a 10g to 50g free sample allowance for qualified corporate research and development pipelines. This program allows process engineers to independently verify particle fluidics, dissolution kinetics, and emulsification compatibility prior to contract deployment.